Nadja Jäkel
University Hospital in Halle(DE)Martin Luther University Halle-Wittenberg(DE)
Publications by Year
Research Areas
Acute Myeloid Leukemia Research, Myeloproliferative Neoplasms: Diagnosis and Treatment, Multiple Myeloma Research and Treatments, Chronic Myeloid Leukemia Treatments, Mast cells and histamine
Most-Cited Works
- → Clinical features and survival of patients with indolent systemic mastocytosis defined by the updated WHO classification(2020)74 cited
- → JAK2 p.V617F allele burden in myeloproliferative neoplasms one month after allogeneic stem cell transplantation significantly predicts outcome and risk of relapse(2013)70 cited
- → The use of erythropoiesis-stimulating agents with ruxolitinib in patients with myelofibrosis in COMFORT-II: an open-label, phase 3 study assessing efficacy and safety of ruxolitinib versus best available therapy in the treatment of myelofibrosis(2015)41 cited
- → Combined bendamustine, prednisone and bortezomib (BPV) in patients with relapsed or refractory multiple myeloma(2012)38 cited
- → Dose Reduced Chemotherapy in Sequence with Blinatumomab for Newly Diagnosed Older Patients with Ph/BCR::ABL Negative B-Precursor Adult Lymphoblastic Leukemia (ALL): Preliminary Results of the GMALL Bold Trial(2023)36 cited
- → Lenalidomide, bendamustine and prednisolone exhibits a favourable safety and efficacy profile in relapsed or refractory multiple myeloma: final results of a phase 1 clinical trial OSHO – #077(2013)32 cited
- → Genotype/phenotype correlations of childhood‐onset congenital sideroblastic anaemia in a European cohort(2019)30 cited
- → Clinical Impact of Skin Lesions in Mastocytosis: A Multicenter Study of the European Competence Network on Mastocytosis(2021)28 cited
- → Non syndromic childhood onset congenital sideroblastic anemia: A report of 13 patients identified with an ALAS2 or SLC25A38 mutation(2017)18 cited
- → Azacitidine-induced reconstitution of the bone marrow T cell repertoire is associated with superior survival in AML patients(2022)14 cited